Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Has pharmacogenetics brought us closer to 'personalized medicine' for initial drug treatment of hypertension?

Current opinion in cardiology - 1 Jul 2009

Arnett Donna K, Claas Steven A, Lynch Amy I

Abstract excerpt

PURPOSE OF REVIEW: To describe recent advances in antihypertensive pharmacogenetics and discuss challenges related to translating this knowledge into 'personalized medicine' for the initial drug treatment of hypertension. RECENT FINDINGS: Recent studies included both prospective and retrospective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antihypertensive Agents
Share to Drug Design
Share to Evidence-Based Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Hypertension

Share to Pharmacogenetics

Share to Renin-Angiotensin System

Share to Time Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 19509486
DOI: 10.1097/HCO.0b013e32832c58ba
PMCID: PMC3926658

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19509486-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Has pharmacogenetics brought us closer to 'personalized medicine' for initial drug treatment of hypertension?PMID 19509486Read ↗

Pharmacogenetics of antihypertensive treatment.Semantic proximity Read ↗

Pharmacogenomics in Hypertension: Where We Stand TodaySemantic proximity Read ↗

The Future of Pharmacogenetics in the Treatment of HypertensionSemantic proximity Read ↗

Pharmacogenomics And Hypertension: Current InsightsSemantic proximity Read ↗

Hypertension precision medicine: the promise and pitfalls of pharmacogenomicsSemantic proximity Read ↗

Genetics, ancestry, and hypertension: implications for targeted antihypertensive therapies.Semantic proximity Read ↗

Pharmacogenomic approaches to study the effects of antihypertensive drugs.Semantic proximity Read ↗

Genetics and hypertension: is it time to change my practice?Semantic proximity Read ↗

Antihypertensive pharmacogenetics: getting the right drug into the right patient.Semantic proximity Read ↗

Advancing management of hypertension through pharmacogenomicsSemantic proximity Read ↗

[Pharmacogenetics--pathway to individualized antihypertensive pharmacotherapy].Semantic proximity Read ↗

Computational and Pharmacogenomic Insights on Hypertension Treatment: Rational Drug Design and Optimization StrategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.